Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol‐lowering treatments?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol‐lowering treatments?

Published:2022-03-24 Issue:7 Volume:52 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Investigation

Author:

Ying Qidi¹^ORCID,Ronca Annalisa²,Chan Dick C.¹^ORCID,Pang Jing¹,Favari Elda²,Watts Gerald F.¹³

Affiliation:

1. Medical School Faculty of Health and Medical Sciences University of Western Australia Perth Western Australia Australia

2. Department of Food and Drug University of Parma Parma Italy

3. Lipid Disorders Clinic Department of Cardiology and Internal Medicine Royal Perth Hospital Perth Western Australia Australia

Funder

National Health and Medical Research Council

Amgen

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13766

Reference46 articles.

1. Cell cholesterol efflux: integration of old and new observations provides new insights

2. Cholesterol Efflux and Atheroprotection

3. High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives

4. Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

5. Cholesterol Efflux Capacity as a Therapeutic Target

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia;JACC: Basic to Translational Science;2024-08

2. PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-Specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia;2024

3. Does fish oil supplementation increase cholesterol efflux capacity in familial hypercholesterolaemia?;European Journal of Clinical Investigation;2023-06-29

4. Cholesterol efflux capacity is increased in subjects with familial hypercholesterolemia in a retrospective case–control study;Scientific Reports;2023-05-24

5. The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors;Cancer Immunology, Immunotherapy;2023-02-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3